Anton Y. Peleg, MBBS PhD MPH FRACP
Anton Y. Peleg, MBBS PhD MPH FRACP
Alfred Hospital and Monash University
Verified email at
Cited by
Cited by
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ...
The Lancet 399 (10325), 629-655, 2022
Acinetobacter baumannii: Emergence of a Successful Pathogen
AY Peleg, H Seifert, DL Paterson
Clinical microbiology reviews 21 (3), 538-582, 2008
Hospital-acquired infections due to gram-negative bacteria
AY Peleg, DC Hooper
New England Journal of Medicine 362 (19), 1804-1813, 2010
Common infections in diabetes: pathogenesis, management and relationship to glycaemic control
AY Peleg, T Weerarathna, JS McCarthy, TME Davis
Diabetes/metabolism research and reviews 23 (1), 3-13, 2007
Medically important bacterial–fungal interactions
AY Peleg, DA Hogan, E Mylonakis
Nature reviews microbiology 8 (5), 340-349, 2010
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...
Jama 320 (10), 984-994, 2018
Treatment of Acinetobacter Infections
J Fishbain, AY Peleg
Clinical infectious diseases 51 (1), 79-84, 2010
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
AY Peleg, S Husain, ZA Qureshi, FP Silveira, M Sarumi, KA Shutt, ...
Clinical Infectious Diseases 44 (10), 1307-1314, 2007
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii
AY Peleg, J Adams, DL Paterson
Antimicrobial agents and chemotherapy 51 (6), 2065-2069, 2007
Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory
C Franklin, L Liolios, AY Peleg
Journal of clinical microbiology 44 (9), 3139-3144, 2006
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
AY Peleg, BA Potoski, R Rea, J Adams, J Sethi, B Capitano, S Husain, ...
Journal of antimicrobial chemotherapy 59 (1), 128-131, 2007
Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics
AY Peleg, S Jara, D Monga, GM Eliopoulos, RC Moellering Jr, ...
Antimicrobial agents and chemotherapy 53 (6), 2605-2609, 2009
Acinetobacter baumannii: evolution of antimicrobial resistance—treatment options
Y Doi, GL Murray, AY Peleg
Seminars in respiratory and critical care medicine 36 (01), 085-098, 2015
Management of meningitis due to antibiotic-resistant Acinetobacter species
BN Kim, AY Peleg, TP Lodise, J Lipman, J Li, R Nation, DL Paterson
The Lancet infectious diseases 9 (4), 245-255, 2009
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
GE Hartley, ESJ Edwards, PM Aui, N Varese, S Stojanovic, J McMahon, ...
Science immunology 5 (54), eabf8891, 2020
Dissemination of the Metallo-β-Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia
AY Peleg, C Franklin, JM Bell, DW Spelman
Clinical Infectious Diseases 41 (11), 1549-1556, 2005
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody
AY Peleg, S Husain, EJ Kwak, FP Silveira, M Ndirangu, J Tran, KA Shutt, ...
Clinical infectious diseases 44 (2), 204-212, 2007
Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus
AY Peleg, S Miyakis, DV Ward, AM Earl, A Rubio, DR Cameron, S Pillai, ...
PloS one 7 (1), e28316, 2012
Insights into Acinetobacter baumannii pathogenicity
GM Cerqueira, AY Peleg
IUBMB life 63 (12), 1055-1060, 2011
The Mechanisms of Disease Caused by Acinetobacter baumannii
FC Morris, C Dexter, X Kostoulias, MI Uddin, AY Peleg
Frontiers in microbiology 10, 1601, 2019
The system can't perform the operation now. Try again later.
Articles 1–20